United States
Germany
Japan
United Kingdom
China
Nos1 - Rat, 4 unique 29mer shRNA constructs in lentiviral GFP vector, 5µg of each construct provided
| Format | Lentiviral plasmids |
| Vector | pGFP-C-shLenti |
Products
Anti-nNOS (C-terminal region) Antibody
| Applications | ICC, IHC, WB |
| Reactivities | Human, Rat, Mouse |
NOS1 - Human, 4 unique 29mer shRNA constructs in retroviral untagged vector, 5µg of each construct provided
| Format | Retroviral plasmids |
| Vector | pRS |
NOS1 (19-31) rabbit polyclonal antibody
| Applications | WB |
| Reactivities | Human |
NOS1 (untagged) - Homo sapiens nitric oxide synthase 1 (neuronal) (NOS1), transcript variant 2
| Type | Human Untagged Clone |
| Tag | Tag Free |
| Vector | pCMV6-Entry |
NOS1 (untagged) - Homo sapiens nitric oxide synthase 1 (neuronal) (NOS1), transcript variant 3
| Type | Human Untagged Clone |
| Tag | Tag Free |
| Vector | pCMV6-Entry |
Nos1 - Rat, 4 unique 29mer shRNA constructs in retroviral untagged vector, 5µg of each construct provided
| Format | Retroviral plasmids |
| Vector | pRS |
Nos1 - Mouse, 4 unique 29mer shRNA constructs in retroviral untagged vector, 5µg of each construct provided
| Format | Retroviral plasmids |
| Vector | pRS |
Transient overexpression of NOS1, transcript variant 1, in HEK293T cells, FFPE control for IHC, ICC and ISH staining, 25 slides per pack
Nos1 (untagged ORF) - Rat nitric oxide synthase 1, neuronal (Nos1), (10 ug)
| Type | Rat Untagged Clone |
| Tag | Tag Free |
| Vector | pCMV6-Entry |
Nos1 (untagged) - Mouse nitric oxide synthase 1, neuronal (Nos1), (10ug)
| Type | Mouse Untagged Clone |
| Tag | Tag Free |
| Vector | pCMV6-Entry |
NOS1 (untagged) - Homo sapiens nitric oxide synthase 1 (neuronal) (NOS1), transcript variant 4
| Type | Human Untagged Clone |
| Tag | Tag Free |
| Vector | pCMV6-Entry |
qSTAR qPCR primer pairs against Mus musculus gene Nos1
Nos1 - Mouse, 4 unique 29mer shRNA constructs in lentiviral GFP vector, 5µg of each construct provided
| Format | Lentiviral plasmids |
| Vector | pGFP-C-shLenti |
